. Haber'ssyndrome may be a clinical entity different from Dowling-Degos disease. Br J Dermatol. 2009 Jan. 160(1):215-7. [QxMD MEDLINE Link]. 39. Braun-Falco M, Volgger W, Borelli S, Ring J, Disch R. Galli-Galli disease: an unrecognized entity or an acantholytic variant of Dowling-Degos disease?. J Am Acad Dermatol. 2001 Nov. 45(5):760-3. [QxMD MEDLINE Link]. 40. Gilchrist H, Jackson
. Haber'ssyndrome may be a clinical entity different from Dowling-Degos disease. Br J Dermatol. 2009 Jan. 160(1):215-7. [QxMD MEDLINE Link]. 39. Braun-Falco M, Volgger W, Borelli S, Ring J, Disch R. Galli-Galli disease: an unrecognized entity or an acantholytic variant of Dowling-Degos disease?. J Am Acad Dermatol. 2001 Nov. 45(5):760-3. [QxMD MEDLINE Link]. 40. Gilchrist H, Jackson
MEDLINE Link]. 38. Nishizawa A, Nakano H, Satoh T, Takayama K, Sawamura D, Yokozeki H. Haber'ssyndrome may be a clinical entity different from Dowling-Degos disease. Br J Dermatol. 2009 Jan. 160(1):215-7. [QxMD MEDLINE Link]. 39. Braun-Falco M, Volgger W, Borelli S, Ring J, Disch R. Galli-Galli disease: an unrecognized entity or an acantholytic variant of Dowling-Degos disease?. J
MEDLINE Link]. 38. Nishizawa A, Nakano H, Satoh T, Takayama K, Sawamura D, Yokozeki H. Haber'ssyndrome may be a clinical entity different from Dowling-Degos disease. Br J Dermatol. 2009 Jan. 160(1):215-7. [QxMD MEDLINE Link]. 39. Braun-Falco M, Volgger W, Borelli S, Ring J, Disch R. Galli-Galli disease: an unrecognized entity or an acantholytic variant of Dowling-Degos disease?. J